Syringes and Needles Market Size Analysis, Drivers, Restraints, Key Factors Forecast, 2023–2028

The global syringes and needles market size was USD 21.70 Billion in 2020 and is expected to register a steady revenue CAGR of 6.5% during the forecast period.

The global Syringes and Needles Market is expected to reach USD 36.13 Billion in 2028 and register a revenue CAGR of 6.5% over the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth are increasing manufacturing of disposable needles and syringes due to increasing COVID-19 vaccination across the globe, increasing blood transfusions, and increasing number of diagnostic tests. 

A syringe is a tool used in medicine to inject or remove fluid from the body. It comprises of a sliding plunger equipped with a hollow cylinder that has a needle connected to it. Fluids or gases can be drawn into or expelled from the syringe by pulling or pushing the piston (plunger) inside the tube. Common applications for these syringes include administering injections, medicinal medicines, vaccinations, or blood collection. Rising rates of chronic illnesses, an increase in the necessity for organ transplants, and an increase in the number of immunisation programmes are the main causes of the surge in syringe demand. The demand for home care settings, safety syringes and needles, and an increase in surgeries are all driving the growth of the global market. In addition, increasing elderly population, increasing demand for disposable syringes in hospitals, diagnostic centers, and clinics, and increasing investments for developing enhanced syringes and needles are other factors driving revenue growth of the global market. 

Request Free Sample Copy @

Some key highlights of the report:

  • Based on type, the biopsy segment is expected to register rapid revenue CAGR over the forecast period to increasing incidence of types of cancer and rare blood diseases, increasing awareness about early diagnosis and biopsy tests, and availability of advanced and safe biopsy needles. 
  • Based on material, the disposable segment is expected to account for significantly larger revenue share between 2021 and 2028 owing to high prevalence of chronic diseases, increasing demand for disposable syringes amidst coronavirus vaccinations, high risk of infection with reusable syringes and needles, rising demand for injectable drugs and increasing number of diagnostic tests. 
  • Among the end use, the hospitals and clinics segment is expected to account for largest revenue share during the forecast owing to high prevalence of chronic diseases, increasing number of surgeries, and improving healthcare facilities. Other factors such as high birth rate, increasing geriatric population, availability of latest injectable devices, and increasing number of clinics and hospitals across the globe are driving revenue growth of the segment. 
  • Europe is expected to account for significant revenue growth over the forecast period. This can be attributed to factors such as high prevalence of chronic and lifestyle-associated diseases, rising number of tests and surgeries, rapid advancements in syringes and needles, increasing presence of well-developed healthcare facilities, and increasing investments for developing advanced and safe needles and syringes. 
  • Asia Pacific market revenue is expected to expand at a rapid CAGR of 8% between 2021 and 2028 owing to increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, improving healthcare facilities, and increasing diagnostic tests and blood collection. In addition, rising investments in research and development activities, increasing healthcare expenditure, increasing number of hospitals and clinics, and increasing vaccination drives are other factors driving revenue growth in Asia Pacific.  

Key Players covered in this report are

DeRoyal, Albert David Ltd, B. Braun Melsungen AG, Terumo Corporation, Connecticut Hypodermics Inc., Insulet, Septodont, Medtronic plc, Becton Dickinson, Schott AG, Cardinal Health Inc., Smiths Medical, Covidien Plc, Thermo Fisher Scientific, Hamilton Company, Merck, Novo Nordisk A/s, and Nipro Medical Corporation.

Product Type Outlook (Revenue, USD Billion, 2018-2028)

  • Blood Collection
  • Drug Delivery
  • Biopsy
  • Dental
  • Ophthalmic
  • Catheter
  • Epidural
  • Anesthesia
  • Others

Material Type Outlook (Revenue, USD Billion, 2018-2028)

  • Reusable
  • Disposable

Application Outlook (Revenue, USD Billion, 2018-2028)

  • Diagnostic
  • General Surgery
  • Orthopedics
  • Respiratory
  • Dental
  • Cardiovascular
  • Neurology

End Use Outlook (Revenue, USD Billion, 2018-2028)

  • Hospitals Clinics
  • Diagnostic Centers
  • Home Care
  • Others

Geographic Segment Covered in the Report:

The Syringes and Needles report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Points covered in this report are as below:

• The Syringes and Needles industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Syringes and Needles Market report provides key statistics on the market status of the Syringes and Needles manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @

I appreciate you reading the report. Additionally take note that we provide report customization based on client needs. Please get in touch with us to learn more about the customisation option, and our staff will deliver a report that is suitable for your needs.

Get Explore Latest Research Report by Reports and Data: 


About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Shubham Bhande

53 Blog posts